Emami Q2 Results Review - Seasonal Volatility Comes To Fore: HDFC Securities

HDFC Securities Institutional Equities

Emami Ltd.’s Q2 FY25 results were marginally ahead of our estimates due to an increased focus on high-margin product portfolios (Healthcare and Pain Management) and a reduction in ad spends (down 6% YoY). Management remains confident in achieving mid to high single-digit volume growth in H2 FY25, driven by the intense winter season, revival in Kesh King, re-launch of the male grooming range, and growth in the international business.

Additionally, expanded distribution in rural areas is expected to benefit the company in H2, as rural recovery gains momentum. We continue to maintain an Add rating with a target price of Rs 750 (30 times Dec-26 earnings per share).

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.